Study S002722

Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05933174
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 220
Start: 2023-10-01
Primary completion: 2027-06-30
Lead sponsor: University Hospitals Cleveland Medical Center
Conditions: Type2diabetes
Interventions: OTHER:Prompt-sheet; OTHER:Usual education
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER_GRANT:Neeland AHA 23SCISA1144816

Registered primary outcomes

Proportion of patients who had a conversation with their primary care provider about SU use and alternatives for their diabetes management [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.